Skip to content

A randomized controlled clinical trial of Huangqi Simiao decoction in the treatment of type 2 diabetes with damp-heat syndrome

A randomized controlled clinical trial of Huangqi Simiao decoction in the treatment of type 2 diabetes with damp-heat syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070936
Enrollment
Unknown
Registered
2023-04-26
Start date
2023-04-26
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

experimental group:Conventional hypoglycemic + Huangqi Simiao decoction
control group:Conventional hypoglycemic + Huangqi Simiao decoction placebo

Sponsors

Tsinghua University Yuquan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? Type 2 diabetes mellitus was diagnosed; ? aged from 18 to 90 years old; ? Conforming to the TCM syndrome differentiation standard of damp-heat syndrome; (4) Primary school or above education, able to read and understand simple sentences; ? patients can provide detailed contact information, have no short-term migration, and are willing to cooperate with follow-up; ? Informed consent, and signed the informed consent.

Exclusion criteria

Exclusion criteria: ? Patients with a history of diabetic ketoacidosis, malignant hypertension, myocardial infarction, cerebrovascular accident, heart failure and other critical diseases within six months; ? recent severe infection (within 4 weeks); (3) serious primary diseases of the heart, liver, brain, kidney and hematopoietic system, cancer or mental illness; (4) pregnant or preparing to become pregnant or lactating women; ? known allergic or severe allergic to traditional Chinese medicine; ? patients who participated in other clinical drug trials within the past 3 months; ? those with insufficient knowledge of the study, unwilling to participate, or poor compliance; Incompatibility (unable to cooperate with diet control, or not according to the prescribed medication and affect the efficacy of the judgment).

Design outcomes

Primary

MeasureTime frame
fasting blood-glucose;postprandial blood glucose;glycosylated hemoglobin;total cholesterol;triglyceride;low density lipoprotein;

Secondary

MeasureTime frame
traditional Chinese medicine syndrome score;

Countries

China

Contacts

Public ContactFeng Xingzhong

Tsinghua University Yuquan Hospital

fengxz9797@sina.com+86 13381128811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026